These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 35563107)

  • 1. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
    Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease.
    Alkhazaali-Ali Z; Sahab-Negah S; Boroumand AR; Tavakol-Afshari J
    Biomed Pharmacother; 2024 Aug; 177():116899. PubMed ID: 38889636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
    Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
    Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.
    Akyuz E; Aslan FS; Gokce E; Ilmaz O; Topcu F; Kakac S
    Eur J Neurosci; 2024 Oct; 60(8):6057-6090. PubMed ID: 39297377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
    Tan L; Yu JT; Tan L
    Mol Neurobiol; 2015; 51(3):1249-62. PubMed ID: 24973986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular miRNA biomarkers in neurologic disease: is cerebrospinal fluid helpful?
    Dhawan A
    Biomark Med; 2021 Oct; 15(15):1377-1388. PubMed ID: 34514843
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases.
    He M; Zhang HN; Tang ZC; Gao SG
    Neural Plast; 2021; 2021():8884642. PubMed ID: 34054944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
    Eyileten C; Sharif L; Wicik Z; Jakubik D; Jarosz-Popek J; Soplinska A; Postula M; Czlonkowska A; Kaplon-Cieslicka A; Mirowska-Guzel D
    Mol Neurobiol; 2021 Jan; 58(1):329-347. PubMed ID: 32944919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of miR-137 in Neurodegenerative Disorders.
    Bodai L; Borosta R; Ferencz Á; Kovács M; Zsindely N
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
    Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
    Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.